FemPulse empowers women worldwide to retake control of their health and lives through bioelectronic medicine. The FemPulse Ring^TM was designed as a discreet and practical treatment option for women with conditions such as overactive bladder (OAB). It is now patented around the world as a platform technology for sensing data and providing personalized neuromodulation therapy for multiple female health conditions.

FemPulse’s vaginal neuromodulation Ring is self-inserted, worn internally, and does not require surgery or the use of pharmaceutical drugs. Its ease-of-use is intended to provide women a more independent and self-directed treatment approach, easily integrated into everyday life.

In the EU: the FemPulse Ring  is now a CE-certified medical device with initial indication the over 50 million European women suffering from OAB.

In the US: following four successful clinical trials, the FemPulse Ring is in a pivotal FDA-approved trial as an investigational device for the over 30 million American women suffering from OAB. Trials for other highly prevalent female health conditions are beginning.